Robalzotan tartrate hydrate -: NAD-299 -: Anxiolytic -: Antidepressant -: 5-HT1A antagonist

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2000年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：775 / 777
页数：3
相关论文
共 50 条
  • [1] PET-Determination of Robalzotan (NAD-299) Induced 5-HT1A Receptor Occupancy in the Monkey Brain
    Lars Farde
    Bengt Andrée
    Nathalie Ginovart
    Christer Halldin
    Seth-Olov Thorberg
    Neuropsychopharmacology, 2000, 22 : 422 - 429
  • [2] PET-determination of robalzotan (NAD-299) induced 5-HT1A receptor occupancy in the monkey brain
    Farde, L
    Andrée, B
    Ginovart, N
    Halldin, C
    Thorberg, SO
    NEUROPSYCHOPHARMACOLOGY, 2000, 22 (04) : 422 - 429
  • [3] Effects of NAD-299, a new, highly selective 5-HT1A receptor antagonist, on bladder function in rats
    Pehrson, R
    Öjteg, G
    Ishizuka, O
    Andersson, KE
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 366 (06) : 528 - 536
  • [4] Effects of NAD-299, a new, highly selective 5-HT1A receptor antagonist, on bladder function in rats
    Rikard Pehrson
    Göran Öjteg
    Osamu Ishizuka
    Karl-Erik Andersson
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2002, 366 : 528 - 536
  • [5] Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist
    Jerning, E
    Svantesson, GT
    Mohell, N
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 360 (2-3) : 219 - 225
  • [6] Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor
    Sandell, J
    Halldin, C
    Hall, H
    Thorberg, SO
    Werner, T
    Sohn, D
    Sedvall, G
    Farde, L
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (02) : 159 - 164
  • [7] The selective 5-HT1A receptor antagonist NAD-299 increases acetylcholine release but not extracellular glutamate levels in the frontal cortex and hippocampus of awake rat
    Kehr, Jan
    Hu, Xiao-Jing
    Yoshitake, Takashi
    Wang, Fu-Hua
    Osborne, Peter
    Stenfors, Carina
    Ogren, Sven Ove
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 (07) : 487 - 500
  • [8] PET examination of [C-11]NAD-299, a new radioligand for visualization of the 5-HT1A receptor.
    Halldin, C
    Sandell, J
    Chou, YH
    Hall, H
    Thornberg, SO
    Werner, T
    Swahn, CG
    Farde, L
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 38P - 38P
  • [9] A 5-HT1A LIGAND WITH BOTH ANTIDEPRESSANT AND ANXIOLYTIC PROPERTIES
    COTT, JM
    KURTZ, NM
    ROBINSON, DS
    LANCASTER, SP
    COPP, JE
    PSYCHOPHARMACOLOGY BULLETIN, 1988, 24 (01) : 164 - 167
  • [10] Selective 5-HT1A antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat
    Misane, I
    Ögren, SO
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (02) : 253 - 264
12345